Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00939120 · ClinicalTrials.gov registry record · Phase 4
Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)
A Phase 4 study of Benign Prostatic Hyperplasia (BPH), sponsored by Siami, Paul F., M.D..
- Completed
- Registry status
- Phase 4
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT00939120 is a Phase 4 study of Benign Prostatic Hyperplasia (BPH) that has completed, run by Siami, Paul F., M.D.. The registered enrollment target is 46 participants, below the 99-participant average among 3 other Benign Prostatic Hyperplasia (BPH) trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00939120, a Phase 4 study of Benign Prostatic Hyperplasia (BPH), has completed, sponsored by Siami, Paul F., M.D..
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an investigator-initiated study of safety, efficacy and tolerability of dutasteride given for 18 months, including a 1-year double-blind randomized co-administration with either tolterodine ER or placebo in men suffering from lower urinary tract symptoms (LUTS) including urgency and frequency, with or without urgency urinary incontinence (i.e., overactive bladder (OAB) symptoms).
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Tolterodine ER 4mg
- DRUG Pre-randomization Dutasteride
Study Locations (1)
Indiana
- Deaconess Clinic Gateway Health Center - Newburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2009-07 |
| Est. Completion | 2014-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00939120
The ClinicalTrials.gov registry entry for NCT00939120 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 99-participant average among 3 other Benign Prostatic Hyperplasia (BPH) trials with a reported enrollment target (54% lower). The listed sponsor is Siami, Paul F., M.D., which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Benign Prostatic Hyperplasia (BPH) appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT00939120 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT00939120 about?
NCT00939120 is a clinical study titled "Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)". This is an investigator-initiated study of safety, efficacy and tolerability of dutasteride given for 18 months, including a 1-year double-blind randomized co-administration with either tolterodine ER or placebo in men suffering from lower urinary tract symptoms (LUTS) including urgency and frequenc...
What is the current status of trial NCT00939120?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2009-07. Estimated completion is 2014-09.
What conditions does trial NCT00939120 study?
This clinical trial studies the following conditions: Benign Prostatic Hyperplasia (BPH).
What interventions are being tested in trial NCT00939120?
The interventions under investigation include: Placebo (DRUG), Tolterodine ER 4mg (DRUG), Pre-randomization Dutasteride (DRUG).
Who is sponsoring clinical trial NCT00939120?
This trial is sponsored by Siami, Paul F., M.D., which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00939120 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Benign Prostatic Hyperplasia (BPH)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.